Expert Review of Anticancer Therapy, Volume 24, Issue 3-4 (2024)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 24, Issue 3-4 (2024)

See all volumes and issues
Volume 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Exploiting c-RAF dependency in RAS mutant cancer: beyond catalytic activity
Sean F. Cooke & Connor M. Blair
Pages: 95-100
Published online: 26 Feb 2024
First Page PreviewforExploiting c-RAF dependency in RAS mutant cancer: beyond catalytic activity | Full Text | References | PDF (2.7 MB) | EPUB | Supplemental
  • 564 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Report
Fixed-duration therapy comes of age in CLL: long-term results of MURANO and CLL14 trials
Stefano Molica & David Allsup
Pages: 101-106
Published online: 29 Nov 2023
AbstractforFixed-duration therapy comes of age in CLL: long-term results of MURANO and CLL14 trials | Full Text | References | PDF (2.1 MB) | EPUB
  • 1287 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Racial and socioeconomic disparities in triple-negative breast cancer treatment
Zouina Sarfraz, Azza Sarfraz, Onaiza Mehak, Ramsha Akhund, Shehar Bano & Hinna Aftab
Pages: 107-116
Published online: 11 Mar 2024
AbstractforRacial and socioeconomic disparities in triple-negative breast cancer treatment | Full Text | References | PDF (1.2 MB) | EPUB
  • 87 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Neo-adjuvant therapies for ER positive/HER2 negative breast cancers: from chemotherapy to hormonal therapy, CDK inhibitors, and beyond
Athina Stravodimou & Ioannis A. Voutsadakis
Pages: 117-135
Published online: 18 Mar 2024
AbstractforNeo-adjuvant therapies for ER positive/HER2 negative breast cancers: from chemotherapy to hormonal therapy, CDK inhibitors, and beyond | Full Text | References | PDF (441.9 KB) | EPUB
  • 106 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review
Riccardo Camedda, Viviana Frantellizzi, Roberta Danieli, Giuseppe De Vincentis & Luca Filippi
Pages: 137-145
Published online: 11 Mar 2024
AbstractforPositron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review | Full Text | References | PDF (2.3 MB) | EPUB
  • 103 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Review Article
Prognostic significance of Dickkopf-1 in head and neck squamous cell carcinoma
Kai Chen, Jin Li, Yanfeng Ouyang, Yulong Xie, Guiqiong Xu, Tianliang Xia, Rui You, Guichao Liu, Han He, Rong Huang & Mingyuan Chen
Pages: 147-154
Published online: 05 Dec 2023
AbstractforPrognostic significance of Dickkopf-1 in head and neck squamous cell carcinoma | Full Text | References | PDF (3.7 MB) | EPUB | Supplemental
  • 82 Views
  • 1 CrossRef citations
  • 0Altmetric
Review Article
The assessment of circulating tumor DNA associated with Wnt/β-catenin signaling pathway as a diagnostic tool for liver cancer: a systematic review and meta-analysis
Xingyuan Ma, Zhe Wang, Shuaiyang Wang, Ye Tian, Bei Xie, Jing Li, Bin Ma & Linjing Li
Pages: 155-167
Published online: 05 Feb 2024
AbstractforThe assessment of circulating tumor DNA associated with Wnt/β-catenin signaling pathway as a diagnostic tool for liver cancer: a systematic review and meta-analysis | Full Text | References | PDF (5.5 MB) | EPUB | Supplemental
  • 140 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Efficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis
Yuqian Feng, Kaibo Guo, Huimin Jin, Jing Jiang, Menglei Wang & Shengyou Lin
Pages: 169-181
Published online: 04 Mar 2024
AbstractforEfficacy and safety of neoadjuvant combination immunotherapy in surgically resectable malignant solid tumors: a systematic review and meta-analysis | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 44 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Efficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing
Ziyi Xu, Yan Li, Lin Wang, Xuezhi Hao, Jianming Ying, Junling Li & Puyuan Xing
Pages: 183-192
Published online: 17 Apr 2024
AbstractforEfficacy of third-generation epidermal growth factor receptor-tyrosine kinase inhibitors in advanced NSCLC with different T790M statuses tested via digital droplet polymerase chain reaction ddPCR and next-generation sequencing | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 367 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Development and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients
Tao Jiang, Sha Yang, Guanghui Wang, Ying Tan & Shu Liu
Pages: 193-203
Published online: 23 Feb 2024
AbstractforDevelopment and validation of survival nomograms in elder triple-negative invasive ductal breast carcinoma patients | Full Text | References | PDF (5.6 MB) | EPUB | Supplemental
  • 67 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles